Quidel Sofia 2 Flu+SARS Antigen FIA (25T)
Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
Supplier: Quidel 20377
- One Sample - Three Results
- Results in 15 minutes
- Dual Work Modes
- Virena Connection
- All necessary components included in kit
- Self-contained Test cassette
- For use with Sofia 2
- FDA Emergency Use Authorization.
|End-User Placement Agreement Required|
|Included and available for purchase|
|Immunofluorescence-based lateral flow technology|
|Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2%|
|Instrument Read - advanced immunofluorescence-based lateral flow|
|15°C to 35°C|
|Influenza A+B and COVID-19/2019-nCOV|
|Direct: Nasal Swab, Nasopharyngael Swab|
|Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100%|
Safety and Handling
ShelfLife : 12 Months from DOM
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok